Skip to content

Clinical trials

Phase 3 Stroke trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Greece Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20061
20071
20081
20091
20111
20121
20131
20143
20181
20191
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Boehringer Ingelheim3
Bayer2
Janssen Research & Development, LLC2
Sanofi2
AstraZeneca1
CSL Behring1
Daiichi Sankyo1
Eli Lilly and Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke19
Myocardial Infarction7
Atrial Fibrillation6
Cardiovascular Diseases5
Coronary Artery Disease3
Heart Failure3
Ischemic Attack, Transient3
Thromboembolism3
Acute Coronary Syndrome2
Atherosclerosis2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.